Project 3:  New Cannabinoid Profiles

CBD3

 

 

 

 

 

 

Location:  Anandia Labs, Inc., British Columbia, Canada.  Research sponsored by 22nd Century Group, Inc.

Objective:  To make an industrial hemp variety with altered profiles of major cannabinoids.  This will lead to new medical marijuana products and potentially new industrial hemp varieties.

Opportunity:  We are engaged in research and development activities in Canada to create unique plant varieties of hemp/cannabis, such as plants with low to no amounts of THC for the legal hemp industry and plants with high levels of CBD and other non-THC cannabinoids for the legal medical marijuana markets.